Prevalence of age-related macular degeneration in the United States.
Explore this paper's citation graph
Summary
Age-related macular degeneration was far more prevalent among white than among black persons, and this number will increase to almost 3 million by 2020 due to the rapid aging of the US population.
- Type
- article
- Published
- 2004-04-01
- Cited by
- 2,937
- References
- 33
- Access
- Open access
- OpenAlex
- https://openalex.org/W1487528435
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:221255190
Keywords
Macular degeneration, Drusen, Demography, Population, Medicine
References
- Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey.
- Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III.
- Prevalence of age-related maculopathy. The Beaver Dam Eye Study.
- Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation.
- The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity.
- Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
- Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
- Age-specific causes of bilateral visual impairment.
- Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study.
- Age‐specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study
- The prevalence of age-related maculopathy: the visual impairment project.
- Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.
- Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.
- Features of Age-Related Macular Degeneration in a Black Population
- An international classification and grading system for age-related maculopathy and age-related macular degeneration
- Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics.
- Activity loss and depression in age-related macular degeneration.
- The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.
- The prevalence of age-related maculopathy in the Rotterdam Study.
- Racial differences in the cause-specific prevalence of blindness in east Baltimore.
Cited by
- New investigations into macular pigment optical density
- Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy.
- Surgery for macular disease
- Trockene altersabhängige Makuladegeneration
- The epidemiology of age related eye diseases in Asia
- Macular degeneration: a disease searching for a cure.
- Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative.
- Health-related quality of life and utility in patients with age-related macular degeneration.
- Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina.
- Introduction: Uveal melanoma
- Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
- AGE-RELATED MACULAR DEGENERATION
- Stemming vision loss with stem cells.
- Intravitreal injection anesthesia--comparison of different topical agents: a prospective randomized controlled trial.
- The burden of age-related macular degeneration: a value-based analysis
- Drusen prevalence and pigmentary changes in Caucasians aged 18–54 years
- Age-related macular degeneration and coronary heart disease: evaluation of genetic and environmental associations.
- EXPRESSION OF SIRT1 IN CHOROIDAL NEOVASCULAR MEMBRANES
- Cognitive Decline and Dementia in the Oldest-Old
- EXACERBATION OF CHOROIDAL AND RETINAL PIGMENT EPITHELIAL ATROPHY AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Related papers
- Drusen Quantification for Early Identification of Age Related Macular Degeneration
- Laser prophylaxis for age-related macular degeneration.
- Development of a Risk Score for Geographic Atrophy (GA) in Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)
- Precursors to Geographic Atrophy in Age-Related Macular Degeneration (AMD)
- Review on Age Related Macular Degeneration
- C3 Variant Is Associated With Neovascular AMD & Geographic Atrophy in Age-Related Macular Degeneration
- A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.
- Age-related macular degeneration treatment: current view (literature review)@@@Amžinės geltonosios dėmės degeneracijos gydymas: dabartinis požiūris (literatūros apžvalga)